Further, the experiments also showed the converse, that anti-angiogenic therapy can improve anti-PD-L1 treatment by generating intratumoural high endothelial venules (HEVs) that facilitate enhanced CTL infiltration, activity, and tumor cell destruction in the breast and neuroendocrine but not the glioma models (79). This evidence concerns the gene CD274 and neoplasm.